Lombard Odier & Cie (Bahamas)’s Gilead Sciences GILD Stock Holding History

Lombard Odier & Cie (Bahamas)’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$6.02M	Sell	61,300 -2,500	-4%	-$278K	2.29%	18
2015 Q2	$7.47M	Hold	63,800	–	–	2.62%	14
2015 Q1	$6.26M	Sell	63,800 -32,300	-34%	-$3.28M	2.26%	18
2014 Q4	$9.06M	Sell	96,100 -62,720	-39%	-$6.49M	3.34%	4
2014 Q3	$16.9M	Sell	158,820 -2,667	-2%	-$261K	6.02%	2
2014 Q2	$13.4M	Buy	161,487 +20,637	+15%	+$1.61M	4.91%	3
2014 Q1	$9.98M	Buy	140,850 +150	+0.1%	+$11.8K	3.95%	4
2013 Q4	$10.6M	Buy	+140,700	New	+$9.8M	4.15%	3

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lombard Odier & Cie (Bahamas)'s GILD Position: Q3 2015 in Review

Lombard Odier & Cie (Bahamas) reduced its Gilead Sciences (GILD) stake by 3.9% in Q3 2015, selling an estimated $278K and leaving 61,300 shares worth $6.02M. The position accounts for 2.29% of the portfolio, ranked #18.

Lombard Odier & Cie (Bahamas) first reported a position in GILD in Q4 2013 and has held it in 8 quarters since. The position peaked at $16.9M in Q3 2014. 1,573 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

Lombard Odier & Cie (Bahamas) held 61,300 shares of Gilead Sciences worth $6.02M as of Q3 2015.
Lombard Odier & Cie (Bahamas) sold 2,500 Gilead Sciences shares in Q3 2015, an estimated $278K.
Gilead Sciences made up 2.29% of Lombard Odier & Cie (Bahamas)'s portfolio in Q3 2015, its #18 holding.
Lombard Odier & Cie (Bahamas) first reported a position in Gilead Sciences in Q4 2013 and has held it in 8 quarters since.
Lombard Odier & Cie (Bahamas)'s Gilead Sciences position peaked at $16.9M in Q3 2014.
1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on Lombard Odier & Cie (Bahamas)'s 13F filing for Q3 2015, filed 13 Nov 2015.